Crescent Grove Advisors LLC Reduces Stock Position in SPDR S&P Biotech ETF $XBI

Crescent Grove Advisors LLC reduced its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 67,024 shares of the exchange traded fund’s stock after selling 5,006 shares during the quarter. SPDR S&P Biotech ETF comprises 0.8% of Crescent Grove Advisors LLC’s investment portfolio, making the stock its 29th biggest position. Crescent Grove Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $8,172,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Cibc World Market Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 8.3% during the 4th quarter. Cibc World Market Inc. now owns 19,523 shares of the exchange traded fund’s stock valued at $2,380,000 after buying an additional 1,490 shares in the last quarter. Calton & Associates Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 3.8% during the 4th quarter. Calton & Associates Inc. now owns 5,441 shares of the exchange traded fund’s stock valued at $663,000 after buying an additional 201 shares in the last quarter. One Capital Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $315,000. Thompson Siegel & Walmsley LLC lifted its stake in shares of SPDR S&P Biotech ETF by 2.6% during the 4th quarter. Thompson Siegel & Walmsley LLC now owns 8,000 shares of the exchange traded fund’s stock valued at $975,000 after buying an additional 200 shares in the last quarter. Finally, Ascension Capital Advisors Inc. purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $1,117,000.

SPDR S&P Biotech ETF Trading Up 1.6%

Shares of XBI stock opened at $129.83 on Thursday. The stock has a market capitalization of $8.28 billion, a P/E ratio of 11.47 and a beta of 0.85. The firm’s 50 day moving average is $131.53 and its 200 day moving average is $126.41. SPDR S&P Biotech ETF has a 12 month low of $80.90 and a 12 month high of $139.19.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.